2Saito H,Dhanasekaran P,Nguyen D. Alpha-helix formation is required for high binding of human apolipoprotein A-I to lipids[J].J Biol Affinity Chem,2004,(20):20974-20981.
4van der Vliet HN,Sammels MG,Leegwater AC. ApolipoproteinA-V:a novel apolipoprotein associated with an early phase of liver regeneration[J].Journal of Biological Chemistry,2001,(48):44512-44520.
5Huard K,Bourgeois P,Rhainds D. Apolipoprotein C-Ⅱ and C-Ⅲ inhibit selective uptake of low-and high-density lipoprotein cholesteryl esters in HepG2 cells[J].International Journal of Biochemistry & Cell Biology,2005,(06):1308-1318.
9Walldius G,Jungner I. Apolipoprotein B and apolipoprotein AI:risk indicators of coronary heart disease and targets for lipidmodifying therapy[J].Journal of Internal Medicine,2004,(02):188-205.
10Nissen SE,Tsunoda T,Tuzcu EM. Effect of recombinant apoA-l Milano on coronary atherosclerosis in patients with acute coronary syndromes:a randomized controlled trial[J].Journal of the American Medical Association,2003,(17):2292-2300.
8Nowak M, Heneboid-Chapman A, Jakel H, et al. Insulin-mediated down-regulation of apolipoprotein A5 gene expression through the phosphatidylinositol 3-kinase pathway: role of upstream stimulatory factor[J]. Mol Cell Bid, 2005, 25(4) :1537 -1548.
9O'Brien PJ, AibornWE, Sloan JH, et al. The novel apolipoprotein A5 is present in human serum, is associated with VLDL, HDL, and chylomicrons, and cireulates at very low concentrations compared with other apolipoproteins [ J ]. Clin Chem, 2005, 51 (2) : 351 - 359.
10Ishihara M, Kujiraoka T, Iwasaki T, et al. A sandwich enzymelinked immunosorbent assay for human plasma apolipoprotein A-V concentration[J]. J Lipid Res, 2005, 46(9) :2015 -2022.
